PEC Chat専用掲示板

[記事表示に戻る] [ツリートップの表示に戻る] 
-『DIlPVXgSWRMs』Houston(1/4-23:41)No.15694
トップに戻る
15694DIlPVXgSWRMsHouston E-mail URL1/4-23:41
記事番号10655へのコメント
I went to http://fonds-voltaire.org/wp/index.php/caliplus-australia-800a.pdf caliplus australia
UCB is seeking approval to market the drug for forms ofinflammatory arthritis that mainly affect the spine and pelvicjoints. These include active axial spondyloarthritis (SpA),ankylosing spondylitis and non-radiographic axialspondyloarthritis (nr-axSpA).